1988
DOI: 10.1038/bjc.1988.236
|View full text |Cite
|
Sign up to set email alerts
|

Glutathione and related enzyme activity in human lung cancer cell lines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
27
0
1

Year Published

1993
1993
2018
2018

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 63 publications
(30 citation statements)
references
References 31 publications
2
27
0
1
Order By: Relevance
“…A549 cells possess enzymes necessary for metabolic activation (41) and have a high level of glutathione (42). We believe that this was crucial for lower LTN % in A549 than in HepG2 cells.…”
Section: Discussionmentioning
confidence: 99%
“…A549 cells possess enzymes necessary for metabolic activation (41) and have a high level of glutathione (42). We believe that this was crucial for lower LTN % in A549 than in HepG2 cells.…”
Section: Discussionmentioning
confidence: 99%
“…Manipulation of cellular glutathione levels is known to influence the sensitivity of cells to UV and ionizing radiation (41) and thus represents a potential cytoprotective pathway. However, no consistent differences have been observed in the cellular content of glutathione or glutathione-metabolizing enzyme activities in classic and variant SCLC (42). A wealth of information has recently highlighted the p53 protein as an important modulator of (5) where loss of functional p53 may increase the threshold of tumor cells to entry into apoptosis.…”
Section: Discussionmentioning
confidence: 99%
“…Low amounts of the MDR1 gene product P-glycoprotein (P-gp), known to confer intrinsic MDR in various human malignancies (review: Bellamy and Dalton, 1994), have been detected in unselected NSCLC cell lines (review: Doyle, 1993). Reduced levels of topoisomerase II (Giaccone et al, 1992) and an increased amount of glutathione-S-transferases (Bai et al, 1996;Carmichael et al, 1988) have been observed in association with chemoresistance. However, all such drug resistance mechanisms could not explain entirely the observed MDR phenotype in NSCLC (Doyle, 1993).…”
mentioning
confidence: 99%